Literature DB >> 8931992

Allele-specific hybridization of lipoprotein lipase and factor-V Leiden missense mutations with direct label alkaline phosphatase-conjugated oligonucleotide probes.

C P Vary1, M Carmody, R LeBlanc, T Hayes, C Rundell, L Keilson.   

Abstract

Direct label alkaline phosphatase (AP) conjugated oligonucleotide probes (AP-DNA) were prepared to assess their utility for allele-specific detection of single base substitutions. Oligonucleotide conjugates were designed to detect point mutations in the genes for lipoprotein lipase (LPL) and coagulation factor-V (FV). Genomic DNA samples, including ones known to harbor point mutations in the genes for LPL and FV, were prepared from whole blood and subjected to polymerase chain reaction (PCR). PCR products were analyzed by Southern hybridization with the allele-specific AP-DNA probes and restriction endonuclease analysis. Thermal profiles for hybridization indicate optimal allele-specific selectivity was achieved with temperatures ranging from 45 degrees C to 55 degrees C at a total Na divided by concentration of 150 mM. Under these conditions the base changes studied were easily discriminated with allele specific hybridization signals in excess of 200:1 as estimated by scanning densitometry. Complete concordance was observed between hybridization and restriction analyses for 175 LPL and 201 FV clinical and reference samples. The total time for analysis of the PCR products was less than 2 h with a dot blot hybridization protocol.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931992     DOI: 10.1016/1050-3862(95)00149-2

Source DB:  PubMed          Journal:  Genet Anal


  2 in total

1.  The Ligamp TP53 Assay for Detection of Minimal Residual Disease in Head and Neck Squamous Cell Carcinoma Surgical Margins.

Authors:  M Luana Poeta; Judith Manola; David Goldenberg; Arlene Forastiere; Joseph A Califano; John A Ridge; Jarrard Goodwin; Daniel Kenady; John Saunders; William Westra; David Sidransky; Wayne M Koch
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

2.  The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.

Authors:  J W Clark; L Snell; R P Shiu; F W Orr; N Maitre; C P Vary; D J Cole; P H Watson
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.